Halo 10 Ultima Pharmaceuticals

Research OverviewHalo 10 Ultima Pharmaceuticals is a fluoxymesterone preparation designed for in-vitro laboratory research into androgenic steroid mechanisms. Fluoxymesterone is a 17α-methylated derivative of dihydrotestosterone, representing a potent androgenic compound with significant research value in steroid receptor studies. This synthetic androgen exhibits strong binding affinity to androgen receptors while demonstrating unique pharmacological properties that distinguish it from other anabolic steroids. Research applications focus on examining its molecular interactions with cellular targets and investigating its distinctive androgenic profile compared to testosterone derivatives. The compound’s structural modifications provide valuable insights into structure-activity relationships within the steroid family.Laboratory ApplicationsResearchers at steroidsshopuk.co.uk examine fluoxymesterone for its exceptional androgenic potency in controlled laboratory environments. Studies investigate its interaction with androgen receptor proteins, evaluating binding kinetics and receptor activation patterns in cellular assays. The compound serves as a reference standard in comparative analyses of fluoxymesterone preparations, enabling researchers to study dose-response relationships and receptor selectivity profiles. Scientific investigations explore its metabolic pathways, examining hepatic metabolism and biotransformation products. Additionally, researchers analyse its effects on gene expression patterns, particularly those related to androgen-responsive elements in target tissues. Comparative studies with selective androgen receptor modulators and research peptides provide valuable insights into receptor pharmacology.Technical SpecificationsHalo 10 Ultima Pharmaceuticals Product SpecificationsParameterSpecificationChemical Name9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-oneCAS Number76-43-7Molecular FormulaC₂₀H₂₉FO₃Molecular Weight336.44 g/molConcentration10mg per tabletManufacturerUltima PharmaceuticalsStorageRoom temperature, dry environmentAppearanceOral tablet formulationResearch ComplianceHalo 10 Ultima Pharmaceuticals fluoxymesterone is manufactured exclusively for in-vitro research applications and analytical testing purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols and maintain appropriate documentation for all experimental procedures. The compound should only be used by qualified scientific personnel in licensed research facilities with adequate safety measures and analytical capabilities.